EPIX (ESSA Pharma) Cyclically Adjusted Book per Share: $2.33 (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EPIX ESSA Pharma Inc EPIX
22 GF Score
Price $0.20
View Full Analysis

What is ESSA Pharma Cyclically Adjusted Book per Share?

ESSA Pharma EPIX 22 Cyclically Adjusted Book per Share is $2.33 as of Jun. 2025. GuruFocus rates EPIX with a GF Score™ of 22/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ESSA Pharma's adjusted book value per share for the three months ended in Jun. 2025 was $2.453. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.33 for the trailing ten years ended in Jun. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-25), ESSA Pharma's current stock price is $0.2012. ESSA Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2025 was $2.33. ESSA Pharma's Cyclically Adjusted PB Ratio of today is 0.09.


ESSA Pharma  (NAS:EPIX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ESSA Pharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.2012/2.33
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ESSA Pharma Cyclically Adjusted Book per Share Related Terms


ESSA Pharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for ESSA Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ESSA Pharma Cyclically Adjusted Book per Share Chart

ESSA Pharma Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.34 2.53

ESSA Pharma Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.44 2.53 2.63 2.41 2.33

EPIX vs SLXN, NLSP, PTNT: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, ESSA Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ESSA Pharma Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ESSA Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ESSA Pharma's Cyclically Adjusted PB Ratio falls into.


EPIX
22GF Score
ESSA Pharma Inc EPIX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ESSA Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ESSA Pharma's adjusted Book Value per Share data for the three months ended in Jun. 2025 was:

Adj_Book= Book Value per Share /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=2.453/129.8920*129.8920
=2.453

Current CPI (Jun. 2025) = 129.8920.

ESSA Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201509 3.940 100.421 5.096
201512 0.590 99.947 0.767
201603 4.735 101.054 6.086
201606 2.243 102.002 2.856
201609 -0.369 101.765 -0.471
201612 1.010 101.449 1.293
201703 -4.054 102.634 -5.131
201706 -1.497 103.029 -1.887
201709 -2.937 103.345 -3.691
201712 -4.342 103.345 -5.457
201803 2.315 105.004 2.864
201806 1.894 105.557 2.331
201809 1.584 105.636 1.948
201812 1.074 105.399 1.324
201903 0.581 106.979 0.705
201906 0.078 107.690 0.094
201909 2.359 107.611 2.847
201912 2.217 107.769 2.672
202003 1.934 107.927 2.328
202006 1.772 108.401 2.123
202009 2.471 108.164 2.967
202012 2.205 108.559 2.638
202103 5.082 110.298 5.985
202106 4.771 111.720 5.547
202109 4.411 112.905 5.075
202112 4.261 113.774 4.865
202203 4.056 117.646 4.478
202206 3.892 120.806 4.185
202209 3.792 120.648 4.083
202212 3.675 120.964 3.946
202303 3.546 122.702 3.754
202306 3.407 124.203 3.563
202309 3.302 125.230 3.425
202312 3.185 125.072 3.308
202403 3.009 126.258 3.096
202406 2.904 127.522 2.958
202409 2.807 127.285 2.864
202412 2.676 127.364 2.729
202503 2.558 129.181 2.572
202506 2.453 129.892 2.453

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $2.33 mean?
ESSA Pharma (EPIX) has a Cyclically Adjusted Book per Share of $2.33 as of Jun. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ESSA Pharma and its competitors.
Is ESSA Pharma's Cyclically Adjusted Book per Share too high?
ESSA Pharma's current Cyclically Adjusted Book per Share is $2.33. Overall, ESSA Pharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does ESSA Pharma's Cyclically Adjusted Book per Share compare to SLXN and NLSP?
ESSA Pharma's Cyclically Adjusted Book per Share of $2.33 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on ESSA Pharma and its competitors. ESSA Pharma's current Cyclically Adjusted Book per Share is $2.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ESSA Pharma stock overvalued right now?
ESSA Pharma (EPIX) has a current Cyclically Adjusted Book per Share of $2.33. The current Cyclically Adjusted Book per Share is $2.33. ESSA Pharma's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For ESSA Pharma (EPIX), the current Cyclically Adjusted Book per Share is $2.33 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ESSA Pharma Business Description

Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
22GF Score

Get the complete analysis for EPIX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price